Exp Clin Endocrinol Diabetes 2012; 120(05): 282-287
DOI: 10.1055/s-0031-1295472
Article
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Metabolic Syndrome Indicators and Target Organ Damage in Urban Active Coping African and Caucasian Men: The SABPA Study

A. de Kock
1   Hypertension in Africa Research Team (HART), School for Physiology, Nutrition and Consumer Sciences, North-West University, Potchefstroom Campus, Potchefstroom, South Africa
,
L. Malan
1   Hypertension in Africa Research Team (HART), School for Physiology, Nutrition and Consumer Sciences, North-West University, Potchefstroom Campus, Potchefstroom, South Africa
,
J. C. Potgieter
2   School for Psychosocial Behavioural Sciences, North-West University, Potchefstroom Campus, Potchefstroom, South Africa
,
W. Steenekamp
3   Medipark Medical Practice, Potchefstroom, 2520, South Africa
,
M. T. van der Merwe
4   Netcare Bariatric Centres of Excellence, University of Pretoria, Pretoria, South Africa
› Author Affiliations
Further Information

Publication History

received 22 August 2011
first decision 05 November 2011

accepted 11 November 2011

Publication Date:
09 January 2012 (online)

Abstract

Psychosocial stress relating to an urban environment or acculturation increases the prevalence of metabolic syndrome (MetS). The objectives of this study were firstly to indicate and compare differences regarding appraisal of stress or active coping responses in urban African (n=88) and Caucasian (n=101) male teachers of South Africa, in accord with the prevalence of MetS indicators. And secondly to investigate the extent to which utilisation of active coping responses, together with MetS indicators, predict target organ damage, in these men. The Coping Strategy Indicator determined high and low active coping responses in male teachers from the Sympathetic Activity and Ambulatory Blood Pressure in Africans (SABPA) study. SABPA inclusion and exclusion criteria were used. Additionally, diabetic medication users (n=8), and participants with renal impairment (n=2) or HIV positive (n=13), were excluded. MetS indicators included glucose, triglyceride, high-density lipoprotein cholesterol, blood pressure, and waist circumference, independent of confounders (age, physical activity, gamma glutamyl transferase). Microalbuminuria and carotid intima-media thickness indicated target organ damage. More MetS indicators exceeded the IDF cut-off points in high active coping African men (14.71%) than in their Caucasian counterparts (3.33%), as determined from χ² analyses. Furthermore, stepwise regressions indicated that more MetS indicators predicted endothelial dysfunction, especially in the high active coping African men. High active coping African men showed more manifestation of MetS, compared to their Caucasian counterparts, and revealed progress towards endothelial dysfunction.

 
  • References

  • 1 Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 20 Oct 2009; 120 (16) 1640-1645
  • 2 American Heart Association Accessed at http://www.americanheart.org on 25 October 2009
  • 3 Amirkhan JH. A factor analytically derived measure of coping: The Coping Strategy Indicator. J Pers Soc Psychol 1990; 59 (05) 1066-1074
  • 4 Amirkhan JH. Criterion validity of a coping measure. J Pers Assess Apr 1994; 62 (02) 242-261
  • 5 Budoff MJ, Nasir K, Mao S et al. Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis Aug 2006; 187 (02) 343-350
  • 6 Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in US adults. Arch Int Med 2004; 140: 167-174
  • 7 Danaei G, Lawes CM, Vander Hoorn S et al. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 11 Nov 2006; 368 (9548) 1651-1659
  • 8 Desmond DM, Shevlin M, MacLachlan M. Dimensional analysis of the coping style indicator in a sample of elderly veterans with acquired limb amputations. J Pers Individual differences Oct 2005; 40 (2006) 249-259
  • 9 Dressler WW. Hypertension in the African American community: social, cultural, and psychological factors. Semin Nephrol Mar 1996; 16 (02) 71-82
  • 10 Du Plessis A, Malan L, Malan NT. Coping and the metabolic syndrome in urban black South African men: the SABPA study. Sept/Oct 2010; 21 (04) 217-223
  • 11 Gaillard T. Insulin resistance and cardiovascular risk in black peopleof the African diaspora. Curr Cardio Risk Rep May 2010; (03) 186-194
  • 12 Kohara K, Nishida W, Maguchi M et al. Autonomic Nervous Function in Non-dipper Essential Hypertensive Subjects: Evaluation by Power Spectral Analysis of Heart Rate Variability. Hypertension 1995; 26: 808
  • 13 Malan L, Malan NT, Wissing MP et al. Coping with urbanization: a cardiometabolic risk? The THUSA study. Biol Psychol Dec 2008; 79 (03) 323-328
  • 14 Malan L, Schutte AE, Malan NT et al. Coping mechanisms, perception of health and cardiovascular dysfunction in Africans. Int J Psychophysiol Aug 2006; 61 (02) 158-166
  • 15 Meijer R, Stork S, Evans GW et al. Striking increases in carotid artery wall thickness in healthy subjects. Cerebrovasc Dis 2010; 30 (05) 448-455
  • 16 Norman R, Bradshaw D, Steyn K et al., South African Comparative Risk Assessment Collaborating Group. Estimating the burden of disease attributable to high cholesterol in South Africa in 2000. S Afr Med J Aug 2007; 97 (8 Pt 2) 708-715
  • 17 Ntyintyane L, Panz V, Raal FJ et al. Leptin, adiponectin, and high-sensitivity C-reactive protein in relation to the metabolic syndrome in urban South African blacks with and without coronary artery disease. Metab Syndr Relat Disord Jun 2009; 7 (03) 243-248
  • 18 Okpechi IG, Pascoe MD, Swanepoel CR et al. Microalbuminuria and the metabolic syndrome in non-diabetic black Africans. Diab Vasc Dis Res Dec 2007; 4 (04) 365-367
  • 19 Oosthuizen W, Vorster HH, Kruger A et al. Impact of urbanisation on serum lipid profiles – the THUSA survey. S Afr Med J Sep 2002; 92 (09) 723-728
  • 20 Port SC, Goodarzi MO, Boyle NG et al. Blood glucose: a strong risk factor for mortality in nondiabetic patients with cardiovascular disease. Am Heart J Aug 2005; 150 (02) 209-214
  • 21 Ross E, Deverell A. Psychosocial approaches to health, illness and disability: A reader for health care professionals. Pretoria: Van Schaik; 2004: 18-19
  • 22 Seedat YK. Perspectives on research in hypertension. Cardiovasc J Afr Jan-Feb 2009; 20 (01) 39-42
  • 23 Stapelberg R. Psychometric characteristics of the COPE and SACS in a Setswana speaking South African group. 1999. M.A. Dissertation-Potchefstroom University for Christian Higher Education. 280p. Available from: http://www.sciencedirect.com/science/copingmechanisms.htm
  • 24 Statsoft, Inc . 2011. STATISTICA for Windows (Computer program manual). Statsoft, Inc; Tulsa, OK:
  • 25 Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) guidelines for the management of arterial hypertension. Vasc Health Risk Manag 2007; 3 (06) 783-795
  • 26 Suzuki S, Kumano H, Sakano Y. Effects of effort and distress coping processes on psychophysiological and psychological stress responses. Int J Psychophysiol Feb 2003; 47 (02) 117-128
  • 27 Watson KE, Topol EJ. Pathobiology of atherosclerosis: are there racial and ethnic differences?. Rev Cardiovasc Med 2004; 5 (Suppl. 03) S14-S21
  • 28 World Health Organisation Assessed at http://www.who.int/mediacentre/factsheets on 15 May 2010
  • 29 World Health Organisation The Global Physical Activity Questionnaire (GPAQ). 2003. Available from: URL: http://www.who.int/entity/chp/stepsresources/GPAQ.htm
  • 30 World Medical Association Declaration of Helsinki Ethical Principles for Medical Research involving Human Subjects 2008 . Available from: URL: http://www.wma.net/e/policy/b3.htm